Expert available to discuss newly-characterized AD mimic and its impact on research/treatment strategies around dementia.

Peter Nelson, MD, PhD, co-chaired an international workgroup of scientists who have defined a disease that shares clinical symptoms of Alzheimer's disease, but has different pathological features. 

The group's work defining this new AD-mimic, called LATE, was published in the latest issue of Brain. Nelson is first author.

Nelson is an experimental neuropathologist focusing on Alzheimer’s disease at the University of Kentucky's Sanders-Brown Center on Aging. His career is motivated partly by his own grandmother, Sylvia “Tib” Becker, who died with Alzheimer's disease.

This isn't Dr. Nelson's first such effort.  He also co-led a multi-institutional study that defined and established criteria for another AD-mimic called primary age-related tauopathy (PART) in 2014. 

 Broadcast studio available


ABOUT THE SANDERS-BROWN CENTER ON AGING (SBCOA): Since 1972, SBCoA has played an instrumental role in several landmark breakthroughs related to Alzheimer's and other dementias, including the discovery that there are changes in the brain decades before there are outward symptoms of the disease.

In 1985, SBCoA was among the first 10 Alzheimer's Disease Centers funded by the National Institutes of Health. Currently, only 31 designated Alzheimer's Disease Centers exist in the U.S. and only nine -- including Sanders-Brown -- have been continuously funded since the designation was launched.